Medrad, Inc. Names Samuel M. Liang as New CEO to Start July 1

Published: May 12, 2010

PITTSBURGH TRIBUNE-REVIEW -- Medical device maker Medrad Inc. today named a new chief executive who will succeed John Friel as of July 1. Friel is retiring from the Marshall-based company and will be replaced by Samuel M. Liang, CEO at Vascular Therapies LLC in Totowa, N.J., since July 2008.

Back to news